Canadian Consortium Formed

OTTAWA—The Canadian Institute of Advanced Studies, which has lured home a number of Canadian scientists through its network of university research fellows (see THE SCIENTIST, April 20, p.1), has now sparked the formation of an industry consortium to put their findings to practical use. Precarn Associates Inc. is a nonprofit association of 22 corporations that, according to its prospectus, “will sponsor, manage and disseminate the results of longterm pre-competitive research projec

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

OTTAWA—The Canadian Institute of Advanced Studies, which has lured home a number of Canadian scientists through its network of university research fellows (see THE SCIENTIST, April 20, p.1), has now sparked the formation of an industry consortium to put their findings to practical use.

Precarn Associates Inc. is a nonprofit association of 22 corporations that, according to its prospectus, “will sponsor, manage and disseminate the results of longterm pre-competitive research projects in the area of intelligent systems and advanced robotics.

The consortium plans to bolster what it calls the “slow and hesitant” nature of current work in the two fields by consulting with the CIAR network of fellows and designing projects to fill those gaps.

Each founding member of the consortium has promised to provide three years of support, at $25,000 Canadian ($17,500 U.S.) annually, plus travel and other expenses. The consortium, which expects to have at least 50 corporate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies